Empowered by Tyler Technologies
Refine Results

The population density of Glendale, AZ was 4,094 in 2018. The population density of Bakersfield, CA was 2,643 in 2018.

Population Density

Population Density is computed by dividing the total population by Land Area Per Square Mile.

Above charts are based on data from the U.S. Census American Community Survey | ODN Dataset | API - Notes:

1. ODN datasets and APIs are subject to change and may differ in format from the original source data in order to provide a user-friendly experience on this site.

2. To build your own apps using this data, see the ODN Dataset and API links.

3. If you use this derived data in an app, we ask that you provide a link somewhere in your applications to the Open Data Network with a citation that states: "Data for this application was provided by the Open Data Network" where "Open Data Network" links to http://opendatanetwork.com. Where an application has a region specific module, we ask that you add an additional line that states: "Data about REGIONX was provided by the Open Data Network." where REGIONX is an HREF with a name for a geographical region like "Seattle, WA" and the link points to this page URL, e.g. http://opendatanetwork.com/region/1600000US5363000/Seattle_WA

Geographic and Population Datasets Involving Bakersfield, CA or Glendale, AZ

  • API

    MCAH Birth File

    data.countyofnapa.org | Last Updated 2024-02-07T17:45:49.000Z

    Data Source: CA Department of Public Health, Maternal Child and Adolescent Health Division This data biography includes information about who created this data, and how, where, when, and why it was collected. We, the epidemiology team at Napa County Health and Human Services Agency, Public Health Division, created it to help you understand where the data we analyze, and share comes from. If you have any further questions, we can be reached at epidemiology@countyofnapa.org. How was the data collected? This data product is the result of the merging of two data files spanning different time periods. The California Birth Statistical Master File from 2007 to 2017 and the California Comprehensive Master Birth File from 2018 to 2021 that replaced the Master File. Additional metrics were included from the calculations off the source datasets. Population Density data from the US Census Bureau American Community Survey 5-year estimates: Poverty States in the past 12 months & Population density data from the California Department of Health Care Access and Information: Healthcare Workforce were included as metrics or to calculate new metrics. Who was included and excluded from the data? Birth records from all live births of birthing parent resident of California collected by vital statistics offices throughout the state. Where was the data collected?  Data was collected for all California counties as well as for the state of California. When was the data collected? 2007-2021 Where can I learn more about this data? Data dictionary for the source files used to build the data product can be found here. Detailed definitions assumed for this data product as well as comments on some of the methodologies applied can be found here. For more information overall, please refer to https://www.cdph.ca.gov/Programs/CFH/DMCAH/surveillance/CDPH%20Document%20Library/Data-Dashboards/About-the-Data-Prenatal-Care.pdf.

  • API

    Weekly COVID-19 cases among persons ≥5 years old among unvaccinated and vaccinated with a BNT162b2 (Pfizer-BioNTech) primary series by age group — 22 U.S. jurisdictions, January 16 to May 28, 2022

    data.cdc.gov | Last Updated 2023-08-02T22:51:45.000Z

    Reported numbers of SARS-CoV-2 infections by age group (5–11, 12–17, 18–49, 50–64, ≥65 years of age) from 22 U.S. jurisdictions (AR, AZ, CA, CO, CT, DC, FL, GA, IN, KS, MI, MA, MN, NC, NE, NJ, NM, NYC, PHL, TN, UT, WI ); ~53% of the U.S. population) with routine linkages between COVID-19 case surveillance and immunization information system (IIS) data reported to CDC during January 16, 2022 – May 28, 2022. Vaccine administration (coverage) data reported to CDC were aggregated by U.S. reporting jurisdiction, MMWR week of vaccination (≥14 days after completing the primary vaccine series), FDA-approved vaccine products, and age group (5–11, 12–17, 18–49, 50–64, ≥65 years). Vaccination status: A person vaccinated with at least a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing BNT162b2 (Pfizer-BioNTech) primary series. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. To estimate the number of unvaccinated persons in each MMWR week, the 2019 U.S. Census population estimates by jurisdiction and age group were used (except for California, where State Department of Finance 2021 population projections were determined to be more accurate). The number of unvaccinated persons each MMWR week was estimated by subtracting the cumulative number of vaccinated (all products) and partially vaccinated persons (all products) from the respective population totals for each jurisdiction and age group. Continuity correction: A continuity correction has been applied to the denominators by capping the percent population coverage at 95%. To do this, we assumed that at least 5% of each age group would always be unvaccinated in each jurisdiction. Adding this correction ensures that there is always a reasonable denominator for the unvaccinated population that would prevent rates from growing unrealistically large due to potential overestimates of vaccination coverage.